Pritesh Shah Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 13 hours ago
Pritesh Shah has an estimated net worth of at least $11.7 million*, as of Feb. 5, 2025. They own 124,511 shares of NVCR stock. They have sold 69,836 shares of NVCR stock since 2021, for an estimated $8.7 million.
Pritesh Shah $NVCR SEC Form 4 Insider Trading
Pritesh Shah has filed a total of 18 insider trades in $NVCR since 2021. Their most recent trade was a sale of 382 shares, made on Nov 07, 2023. Their largest trade was a sale of 23,540 shares, made on Jun 10, 2021. We estimate that they now own 124,511 shares of $NVCR, worth an estimated $2.9 million.
Insider Trading at $NVCR
There have been a total of 152 insider trades reported at $NVCR since 2021, with 4,974 shares purchased and 544,572 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a sale of 2,160 shares reported by Mukund Paravasthu (Chief Operating Officer), made on Jan 11, 2025.
History of Insider Stock Trades by Pritesh Shah
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NVCR
|
Sale | 382 | Nov 07, 2023 | Nov. 8, 2023, 5:22 p.m. |
|
NVCR
|
Sale | 273 | Sep 01, 2023 | Sept. 5, 2023, 4:23 p.m. |
|
NVCR
|
Sale | 16,909 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
NVCR
|
Sale | 2,942 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
NVCR
|
Sale | 1,570 | Mar 03, 2023 | March 7, 2023, 5:52 p.m. |
|
NVCR
|
Sale | 937 | Mar 02, 2023 | March 6, 2023, 5:41 p.m. |
|
NVCR
|
Sale | 1,923 | Mar 01, 2023 | March 2, 2023, 6 p.m. |
|
NVCR
|
Sale | 387 | Jan 05, 2023 | Jan. 9, 2023, 7:20 p.m. |
|
NVCR
|
Sale | 269 | Sep 02, 2022 | Sept. 6, 2022, 5:12 p.m. |
|
NVCR
|
Sale | 3,669 | Mar 09, 2022 | March 11, 2022, 5:54 p.m. |
|
NVCR
|
Sale | 2,481 | Mar 08, 2022 | March 9, 2022, 5:56 p.m. |
|
NVCR
|
Sale | 5,294 | Mar 07, 2022 | March 9, 2022, 5:56 p.m. |
|
NVCR
|
Sale | 997 | Mar 03, 2022 | March 7, 2022, 7:23 p.m. |
|
NVCR
|
Sale | 1,914 | Mar 04, 2022 | March 7, 2022, 7:23 p.m. |
|
NVCR
|
Sale | 2,632 | Mar 04, 2022 | March 7, 2022, 7:23 p.m. |
|
NVCR
|
Sale | 2,063 | Aug 04, 2021 | Aug. 5, 2021, 8 p.m. |
|
NVCR
|
Sale | 1,654 | Aug 03, 2021 | Aug. 3, 2021, 8 p.m. |
|
NVCR
|
Sale | 23,540 | Jun 10, 2021 | June 10, 2021, 8 p.m. |
$NVCR Executives and Stock Owners with Insider Trades
-
Frank X Leonard, Chief Development Officer
-
Frank X Leonard, President, CNS Cancers US
-
Ashley Cordova, Chief Financial Officer
-
Asaf Danziger, Chief Executive Officer
-
Wilhelmus Cm Groenhuysen, Chief Operating Officer
-
Pritesh Shah, Chief Commercial Officer
-
Ely Benaim, Chief Medical Officer
-
William Patrick Burke, Chief Human Resources Officer
-
Pritesh Shah, Chief Growth Officer
-
Frank X Leonard, EVP, Pres., Novocure Oncology
-
Uri Weinberg, Chief Science Officer
-
Mukund Paravasthu, Chief Operating Officer
-
Todd Christopher Longsworth, General Counsel
-
William F Doyle, Executive Chairman
-
Michal Nath Puri, Chief Human Resources Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.